The SEC’s recent statement highlights increased focus on private credit valuations, disclosures, and fair value practices. See the key considerations for fund managers.

Valuation Research Corp.

Industry Update: Medical Devices

Just released! VRC’s latest Industry Update on Medical Devices for relevant market data, trends in EBITDA multiples, notable deals and more.

Scott Slade

Scott Slade is responsible for business development in the Chicago office. He regularly works with public and private companies and private equity firms, assisting them…

Kevin Gawron

Mr. Gawron is part of the portfolio valuation group specializing in valuations of privately-held debt securities, equity securities, and business enterprises for financial reporting purposes.…

Larry Van Kirk

Mr. Van Kirk is a practice leader for closely-held company valuations (estate, FLP, Section 409A) and financial reporting related valuations (ASC 805, ASC 350/360, ASC…

Jason Storbeck

Jason Storbeck specializes in the valuation of business enterprises, intangible assets for purchase price allocations, goodwill impairment studies, and stock compensation expense for financial reporting…

Andrew Reddington

Mr. Reddington specializes in the valuation of businesses, securities and intangible assets for financial reporting, tax and litigation purposes. Prior to joining VRC, Mr. Reddington…

Pharmaceuticals

In order to comply with Accounting Standards Codification 815 (ASC 815), an early stage pharmaceutical company asked VRC to analyze the entire convertible callable note and determine the fair market value of each of the embedded derivatives.